Coherus Oncology Inc at JPMorgan Healthcare Conference Transcript
Good morning everyone. It's still the morning. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the Senior Biotech Analysts here at the firm.
On stage, we have the team from Coherus Oncology. I will now pass the mic to Dennis Lanfear, who is our CEO, for a short presentation, followed by a live audience Q&A. Denny, the stage is yours.
Thank you, Brian, and thank you to the organizers for having us again. I'm happy today to give you an update on the progress of the company over the past 12-months since the last time we chatted with you at the organization. Let me first apprise you, of course, of the forward-looking statements and direct you to the company's SEC filings for comments specifically to LOQTORZI, Tagmokitug and Casdozokitug.
Today, I'll talk to you about a few things, but I'll spend some time, first of all, talking about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
